Recursion Pharmaceuticals (RXRX) ended the recent trading session at $4.65, demonstrating a -4.12% change from the preceding day's closing price. This move lagged the S&P 500's daily gain of 0.26%.

Parth is a technology analyst and writer specializing in the comprehensive review and feature exploration of the Android ecosystem. His work is distinguished by its meticulous focus on flagship ...

When I last covered the self-styled TechBio company Recursion Pharmaceuticals, Inc. (RXRX) in early October, I was attempting to find reasons why the company's share price was on the rise, up from ~$4 ...

Background: Generative artificial intelligence (AI) tools are increasingly being used as “ambient scribes” to generate drafts for clinical notes from patient encounters. Despite rapid adoption, few ...

We are all intrigued by error notes. They offer something different, an unexpected treat for the eyes that you may have never seen before. That's what makes them so ...

Have you ever found yourself frantically scribbling down notes from a meeting, struggling to copy a recipe from a magazine, or trying to preserve the details of a handwritten letter? These moments can ...

Voice notes are an incredibly convenient way to capture ideas, reminders, or important information without needing to type or write. Whether you’re using an iPhone or an Android device, we’ll walk you ...

Investors sold out of the biotech following a quarterly earnings release this morning. The company posted a deeper-than-expected net loss. It's common for clinical-stage biotech companies to post net ...

Anu is a Features author at Android Police. You'll find her writing in-depth pieces about automation tools, productivity apps, and explainers. Before joining AP, she used to write for prominent tech ...